| scholarly article | Q13442814 |
| P2093 | author name string | Guohua Xi | |
| Richard F Keep | |||
| Ya Hua | |||
| Masanobu Okauchi | |||
| P2860 | cites work | Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase | Q24548047 |
| Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease | Q28145899 | ||
| Progression of mass effect after intracerebral hemorrhage | Q28198134 | ||
| Evidence for apoptosis after intercerebral hemorrhage in rat striatum | Q28577314 | ||
| Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia | Q28582000 | ||
| Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells | Q31160300 | ||
| Tissue transglutaminase: a possible role in neurodegenerative diseases | Q33881855 | ||
| Gene regulation and DNA damage in the ageing human brain | Q34326236 | ||
| Type 2 transglutaminase and cell death. | Q36061280 | ||
| Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
| Transglutaminase 2 in inflammation | Q36486713 | ||
| Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats | Q36752639 | ||
| Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. | Q40457537 | ||
| Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress | Q40725013 | ||
| Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products | Q42170839 | ||
| Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats | Q42464660 | ||
| Intracerebral hemorrhage-induced neuronal death | Q42503455 | ||
| Tissue-transglutaminase in rat and human brain: light and electron immunocytochemical analysis and in situ hybridization study | Q43806434 | ||
| Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration | Q43819036 | ||
| Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine | Q43873037 | ||
| Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord | Q44028734 | ||
| Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders | Q44233701 | ||
| Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats | Q44899092 | ||
| Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia | Q44917306 | ||
| Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease | Q45296331 | ||
| The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase | Q45296905 | ||
| Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease | Q45297332 | ||
| Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. | Q45298533 | ||
| Estrogen therapy for experimental intracerebral hemorrhage in rats | Q46668717 | ||
| Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial | Q47622762 | ||
| Experimental intracerebral mass: description of model, intracranial pressure changes and neuropathology | Q48104900 | ||
| Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning | Q48194280 | ||
| Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. | Q48455875 | ||
| Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity | Q48460483 | ||
| Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage | Q48466283 | ||
| Behavioral tests after intracerebral hemorrhage in the rat. | Q48475050 | ||
| Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. | Q48537185 | ||
| Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage | Q48617707 | ||
| Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage | Q49030403 | ||
| Up-regulation of tissue-type transglutaminase after traumatic brain injury | Q58115382 | ||
| Apoptosis as a Form of Cell Death in Intracerebral Hemorrhage | Q73280625 | ||
| Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes | Q77757582 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 229-236 | |
| P577 | publication date | 2008-10-28 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits | |
| P478 | volume | 1249 |
| Q48445336 | Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice |
| Q33912442 | Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription |
| Q37809948 | Exploring Neuroprotective Drug Therapies for Intracerebral Hemorrhage |
| Q35801721 | Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage |
| Q36106030 | Iron enhances the neurotoxicity of amyloid β. |
| Q41038343 | Jugular Venous Reflux Is Associated with Perihematomal Edema after Intracerebral Hemorrhage |
| Q42493460 | Microglia Activation and Polarization After Intracerebral Hemorrhage in Mice: the Role of Protease-Activated Receptor-1. |
| Q37967368 | Recent advances in the development of tissue transglutaminase (TG2) inhibitors |
| Q33525390 | Reference genes for normalising gene expression data in collagenase-induced rat intracerebral haemorrhage |
| Q36877739 | Susceptibility to intracerebral hemorrhage-induced brain injury segregates with low aerobic capacity in rats. |
| Q36241237 | Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation |
| Q26824549 | Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block |
| Q53262522 | Treatment of intracerebral hemorrhage in animal models: meta-analysis. |
Search more.